Dr. Ritter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
505 S Nolen Dr
Southlake, TX 76092Phone+1 817-424-1525Fax+1 817-424-3491- Is this information wrong?
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 1990 - 1993
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1987 - 1990
- University of Texas Southwestern Medical SchoolClass of 1987
Certifications & Licensure
- TX State Medical License 1988 - 2024
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Start of enrollment: 2021 Jun 25
Roles: Principal Investigator
Publications & Presentations
PubMed
- Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry.Hans H Herfarth, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla, Robert McCabe, Benjamin L Cohen, Ryan C Ungaro, Will Harlan, John Hanson, Gauree G Konije...> ;Clinical and Translational Gastroenterology. 2024 Mar 1
- 1 citationsPrior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.Konstantinos Papamichael, Niels Vande Casteele, Bincy P Abraham, Timothy Ritter, Anjali Jain, Adam S Cheifetz> ;Clinical Gastroenterology and Hepatology. 2023 Oct 1
- 9 citationsRapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial.Silvio Danese, Marc Ferrante, Brian G Feagan, Laurent Peyrin-Biroulet, Toshifumi Hibi, William J Sandborn, Stefan Schreiber, Timothy Ritter, Edward V Loftus Jr, Gerhar...> ;The American Journal of Gastroenterology. 2023 Jan 1
- Join now to see all
Press Mentions
- Expert: Fatty Liver Disease Is the Next Healthcare EpidemicAugust 19th, 2019
- More Real-World Data and New Analyses of Data for REBYOTA® (Fecal Microbiota, Live – Jslm) Presented at IDWeek 2023October 15th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: